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The burden of tuberculosis (TB) worldwide is significant, causing 
an estimated 5% of global paediatric deaths annually.[1] South Africa 
(SA) is known to have a high burden of disease,[2] with children 
accounting for 10 - 20% of all TB cases. Less than 2% of new cases 
in SA are due to multidrug-resistant (MDR)-TB.[1,3] Extraspinal 
osteoarticular (ESOA) TB comprises only 2 - 3% of all TB cases.[4] 
Children are more likely than adults to contract ESOA TB owing 
to increased bacterial adherence and venous stasis in tortuous 
metaphyseal vessels. Diagnosis can be difficult with paucibacillary 
disease, indolent presentation, nonspecific blood and imaging 
findings, and adequate tissue samples being difficult to obtain.[1,4,5] 
Early diagnosis and effective treatment are usually critical for full 
recovery, since the results of non-treatment or delays in treatment 
can be debilitating.[1,5-7]
MDR-TB is defined as Mycobacterium tuberculosis that is resistant 
to both isoniazid (INH) and rifampicin (RIF), regardless of other 
susceptibilities.[1] Exposure to MDR-TB is the primary mode of 
spread, so early detection is imperative to limit spread. In SA, MDR-
TB has been declared an epidemic in its major centres.[8,9] There is no 
literature that explores ESOA MDR-TB in children.
Objectives
To describe the epidemiology and highlight the potential problem of 
ESOA MDR-TB infections as seen in children from a single academic 
hospital in SA.
Methods
A retrospective chart review of children diagnosed with ESOA 
TB was performed. All the patients were hospitalised at Chris 
Hani Baragwanath Academic Hospital, Soweto, Johannesburg, 
between 1 January 2006 and 31 December 2015. The National 
Health Laboratory Service database was used to access results. The 
diagnosis of TB was solely based on the child having a positive TB 
culture (acid-fast bacilli (AFB) taken from the affected site (fluid or 
tissue)). Organism culture was performed using the Mycobacterial 
Growth Indicator Tube (MGIT 960) method, and drug sensitivity 
testing was done. All children aged ≤14 years with ESOA TB 
with positive TB culture results were included in the study. All 
other children who were diagnosed with ESOA TB on clinical 
grounds and treated with the standard protocol for ESOA TB were 
excluded, as the main aim of the study was to review children with 
ESOA MDR-TB. Polymerase chain reaction (PCR) testing was not 
done routinely in the study and therefore could not be used for 
assessment.
The following blood results were recorded: white cell count 
(WCC), C-reactive protein (CRP) level, erythrocyte sedimentation 
rate (ESR) and HIV enzyme-linked immunosorbent assay (ELISA). 
All histology specimens that were taken were recorded, specifically 
looking for chronic granulomatous inflammation and the presence 
of Langerhans multinucleated giant cells to confirm the diagnosis 
of TB.
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Background. South Africa (SA) is known to have a high disease burden of tuberculosis (TB). Extraspinal osteoarticular multidrug-resistant 
tuberculosis (ESOA MDR-TB) in children has only been described in a few case reports worldwide.
Objectives. To describe the epidemiology and highlight the potential problem of ESOA MDR-TB infections as seen in children from a single 
academic hospital in SA.
Methods. A retrospective record review was performed on all children diagnosed with ESOA TB infection at Chris Hani Baragwanath Academic 
Hospital, Johannesburg, between 1 January 2006 and 31 December 2015. All patients with a positive TB culture (fluid or tissue) from the surgical 
site of biopsy (bone or joint) and who were hospitalised were included. Organism culture and drug sensitivity testing were performed.
Results. Overall 19 cases of ESOA TB were identified. Areas involved included the shoulder (2 cases), elbow (2 cases), hip (7 cases), knee (4 
cases), ankle (3 cases) and humerus (1 case). The mean age of the population was 7.7 (range 2.0 - 14.0) years. The mean white cell count was 
11.3 (range 5 - 28.9) × 109/L, the mean C-reactive protein level 53.8 (range 1.0 - 364.0) mg/L and the mean erythrocyte sedimentation rate 35.5 
(range 4.0 - 85.0) mm/h. Two cases (10.5%) were MDR, and a further case (5.3%) was resistant to isoniazid only. Four of 12 patients tested 
positive for HIV. One of the HIV-positive patients was isoniazid resistant. The two positive ESOA MDR-TB cases are discussed in detail.
Conclusions. These findings indicate that ESOA MDR-TB is a reality in this paediatric population (10.5%) and a high index of suspicion 
should be maintained, especially when cultures are negative in children with signs and symptoms of ESOA TB. The effect of HIV infection 
on the incidence of ESOA MDR-TB requires further study.
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Results
Over the 10-year study period there were 19 cases of culture-positive 
ESOA TB. Sixteen of the cases were sensitive to all drugs. Two cases 
(10.5%) were MDR, and neither tested positive for HIV. One case was 
resistant to INH, and this patient was HIV-positive. The mean age for 
the total group was 7.7 (range 2.0 - 14.0) years. The mean WCC was 
11.3 (range 5 - 28.9) × 109/L, the mean CRP level was 53.8 (range 1.0 - 
364.0) mg/L, and the mean erythrocyte sedimentation rate (ESR) was 
35.5 (range 4.0 - 85.0) mm/h. Twelve patients were tested for HIV, 4 
of whom were HIV-positive (33.3%). Histological examination was 
performed on 12 specimens, and 10 confirmed features in keeping 
with TB, namely chronic granulomatous inflammation.
The MDR cases
Case 1
A 2-year-old girl, who had previously been well, presented with a 
2-day history of swelling, tenderness and decreased movement of 
the right arm. On examination she was febrile and had a warm, 
swollen right shoulder and elbow with associated pseudoparalysis 
of both joints. She had leucocytosis (WCC 19.85 × 109/L) with a low 
haemoglobin concentration (10.6 g/dL). A diagnosis of acute bacterial 
osteoarticular infection was made and intravenous ceftriaxone 
therapy was initiated. She was then taken as an emergency to the 
operating theatre for arthrotomy of the right shoulder and elbow 
joints. A large amount of purulent material was evacuated from both 
joints, and a thorough washout was performed. Swabs, fluid and 
tissue samples were sent for standard bacterial and mycobacterial 
culture and sensitivity, and tissue samples were sent for histological 
examination. Postoperatively the leucocytosis resolved by day 2, but 
the ESR and CRP remained elevated at 133 mm/h and 367.8 mg/L, 
respectively. The antibiotic was changed to intravenous cloxacillin 
based on a pus culture result of sensitive Staphylococcus aureus. 
Blood cultures were negative for bacterial growth and pus samples 
were negative for AFB. The histological findings were remarkable 
for synovitis with an inflammatory infiltrate and bacterial colonies, 
but no granulomatous changes, and negative Ziehl-Neelsen and 
periodic acid-Schiff (PAS) stains. A relook arthrotomy after 3 days 
was negative.
Clinical recovery was complete after 2 weeks of intravenous 
cloxacillin, followed by 4 weeks of oral cloxacillin. After 6 weeks, 
mycobacterial culture and sensitivity results from the right shoulder 
tissue biopsy specimen revealed M. tuberculosis resistant to INH 
and RIF. Owing to a fully resolved clinical picture, negative CRP 
(1.0 mg/L), a mildly elevated ESR (50 mm/h), negative HIV ELISA 
and negative blood and sputum TB cultures, it was decided not to 
administer anti-TB treatment. At follow-up after 1 year, the patient 
had close to full range of movement in the shoulder and elbow joints 
and the ESR was 22 mm/h. Radiographs of the right humerus and 
elbow joint showed no active disease, but areas of healed infective 
changes were visible.
Case 2
A 12-year-old boy on chronic prednisone and methotrexate treatment 
for resistant juvenile dermatomyositis was referred with a residual 
fixed-flexion contracture of his right knee. The dermatomyositis 
was difficult to control, with recurrent ulcerations and vasculitic 
rashes despite ongoing methotrexate and prednisone treatment. The 
previous history revealed that at the age of 6 years he had developed 
a spontaneous abscess just distal to the right knee, which cultured 
vancomycin-sensitive methicillin-resistant S. aureus. This resolved 
completely after surgical drainage and 2 weeks of intravenous 
vancomycin and further oral clindamycin. During his 7th year, he 
developed septic arthritis of the right knee and elbow, which cultured 
methicillin-sensitive S. aureus and was treated with another surgical 
drainage and cloxacillin for 6 weeks. At 7 years of age, a BACTEC 
culture was positive for M. tuberculosis after he presented with 
recurrent swelling and draining sinuses from his right knee and 
wrist. Standard anti-TB therapy was initiated and significant clinical 
improvement of affected joints was noted after 1 month. One month 
later, he returned with a recurrent abscess in his right leg, with a 
positive tissue culture for INH-resistant, RIF-sensitive TB. Therapy 
was reinitiated with RIF, INH, ethionamide (ETA) and pyrazinamide 
(PZA). Again clinical improvement was noted, and after a finding of 
mildly elevated transaminases after 17 months of treatment, PZA was 
removed from the therapeutic regimen. Treatment was discontinued 
after a total of 20 months. Methotrexate was discontinued after the 
initial diagnosis of TB and restarted 2 months after the final dose of 
triple therapy for the monoresistant TB.
On the patient’s most recent admission, the knee had multiple 
surgical scars from previous arthrotomies for bacterial septic arthritis 
and ankylosis at 80o of flexion, and was painful (Fig. 1). Pain and 
globally limited range of motion were also evident in the right hip. 
There were no draining sinuses. Radiographs showed a periosteal 
reaction in the mid-shaft of the right femur, symmetrical loss of joint 
space in the knee with osteopenia, preservation of the physes and no 
bony erosions (Fig. 2). Radiographs of the right hip were remarkable 
for complete loss of joint space with extensive femoral and acetabular 
bone loss (Fig. 3). The WCC was normal at 7.89 × 109/L, but the ESR 
Fig. 1. Case 2. Clinical picture of knee flexion contracture and scarred 
sinuses.
Fig. 2. Case 2. Lateral radiograph of the knee showing destruction of joint.
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was elevated at 40 mm/h. He was taken to the operating theatre for 
manipulation of the right knee and biopsy of the right hip. Purulent 
material and tissue were evacuated from the hip and sent for 
histology, microscopy, and bacterial and mycobacterial culture and 
sensitivity testing. Histological findings were of extensive necrotising 
granulomatous inflammation, positive Ziehl-Neelsen staining and 
a negative PAS stain. PCR testing of the specimen was performed 
after a positive TB culture, and revealed resistance to INH and RIF. 
Treatment with streptomycin, amikacin and ciprofloxacin was given 
for a total of 24 months. At last clinical follow-up, his hip and knee 
remained ankylosed but were no longer painful or inflamed.
Discussion
The study presents 19 paediatric ESOA TB culture-positive cases over 
10 years. Two cases of MDR-TB comprised 10.5% of the total of 19 
cases seen. One case (5.3%) was INH resistant only. ESOA MDR-TB 
is rarely reported, especially in children, and these two cases add 
to the extremely sparse literature on paediatric ESOA MDR-TB. 
Previous publications are limited to case reports and subanalyses of 
populations consisting of adults and children with pulmonary MDR-
TB.[10-12] A series from Cape Town, SA, potentially represents the 
largest case series of paediatric MDR-TB to date. Among 238 children 
with clinically diagnosed TB, 6 cases were osteoarticular, and 8 cases 
overall were identified as MDR-TB. Unfortunately, it is not clear 
how many of the MDR-TB cases were osteoarticular.[3] Of 106 cases 
of paediatric osteoarticular TB over 20 years prior to 2001 in Rabat, 
Morocco, none were identified as drug resistant, and all 80 patients 
who were not lost to follow-up reportedly recovered fully after first-
line therapy.[13] This study is the largest review of ESOA MDR-TB to 
date in the English literature.
Spontaneous remission of ESOA MDR-TB, as in case 1, has not 
been recorded previously. This is the first known case of clinical 
resolution of symptoms in a joint with proven bacterial septic 
arthritis and concomitant MDR-TB infection without TB treatment. 
Potential possibilities are a latent infection in the face of bacterial 
superinfection, actual spontaneous clearance of the pathogen, or an 
incorrectly labelled specimen. To the authors’ knowledge, there are 
no recent reports of spontaneous remission even of sensitive TB, 
although in the pre-antibiotic era, ~50% of those with active disease 
did survive at least into clinical cure.[14] Only two studies address the 
possibility of spontaneous cure. Winqvist et al.[15] found that current 
rates of TB in Sweden are far lower than would be expected given 
the estimated incidence of infection in the pre-antibiotic era, and 
reactivation from age-related immunocompromise. Their conclusion 
was that some probands were actually eradicating the mycobacterium 
without the assistance of antibiotics.[15] When examining the cellular 
immunity profiles of 27 survivors of active TB who never received 
antimycobacterial chemotherapy, Vynnycky and Fine[14] found seven 
patients with antimycobacterial-appropriate central memory T cells 
in the absence of effector memory T cells, indicating proof of 
previous active infection in the absence of any persisting antigen.[16] 
These articles, although interesting, have not changed the authors’ or 
current World Health Organization (WHO) management guidelines 
for the treatment of ESOA MDR-TB.[1]
The relationship of immunity to MDR-TB has been estab-
lished. [3,11] Case 2 had immunocompromise due to dermatomyositis 
and its treatment, and the isoniazid-resistant patient was HIV-
positive. Although there have been no specific investigations of the 
relationships between immunocompromise and development of 
ESOA MDR-TB in any population, the immunocompromised state 
has been associated with an increased prevalence of pulmonary 
MDR-TB[17] and increased mortality from MDR-TB.[18] Drobniewski 
et al.[18] found a nine times greater relative risk of mortality in 
immunocompromised compared with non-immunocompromised 
patients, with a significant reduction of risk if appropriate treatment 
was initiated rapidly. In the current study, HIV testing in 12 patients 
resulted in 4 positive cases (33.3%). Neither of the ESOA MDR-TB 
cases was HIV-positive. Given the current prevalence of HIV in the 
study population, there appears to be no strong relationship between 
HIV infection and ESOA MDR-TB. This has been corroborated by 
studies including the same study population.[3,7,10-13,19,20]
Both cases of osteoarticular MDR-TB had a history of concomitant 
bacterial infection in the same site at which the TB was found. No 
other studies on ESOA MDR-TB have delineated a relationship 
between TB and bacterial co-infection. However, it has been 
shown in human immunological studies[21] that infection with 
helminths decreases cellular immunity to TB. In a mouse model of 
malaria-associated acute respiratory distress syndrome, co-infection 
with Plasmodium berghei caused a significant exacerbation of TB 
infection. [22] Furthermore, antibody titres against influenza A/
H3N2 were higher in a cohort of Indonesians with new clinical 
manifestations of TB than in controls, and highest in those with 
the most severe manifestations of TB.[23] Since viral and parasitic 
infections increase susceptibility to TB activation/infection, it is 
plausible that bacterial infection may have the same negative 
immune-modulatory effect in children with ESOA MDR-TB. It is 
certainly interesting to think that treatment of a bacterial infection 
in case 1 may have resulted in cure or latency of the TB co-infection.
Standard drug susceptibility testing requires a positive culture, 
which is only present in ~40% of cases[5,7,24,25] and gives results at an 
average of 36 - 45 days after sample collection.[7] Many molecular-
based tests have been developed to improve the detection and 
susceptibility of MDR-TB, but unfortunately were not available 
for many of the patients in this cohort.[25-27] Use of the GenoType 
MTBDRplus assay has been shown to reduce time to initiation of 
appropriate drug therapy by 25 days compared with BACTEC MGIT 
960 in rural SA.[28] Many new diagnostic technologies have been 
described in the most recent report on TB by the WHO to improve 
lag time to diagnosis and sensitivity testing for appropriate treatment 
of MDR-TB.[1]
Donald[24] recommended the following treatment in children with 
osteoarticular TB: 2 months of triple-therapy intensive phase with 
INH 5 - 15  mg/kg/d, RIF 10 - 20 mg/kg/d and PZA 30 - 40 mg/
Fig. 3. Case 2. Anteroposterior radiograph of the pelvis showing destruction 
of the right hip joint with erosions of the femoral head and joint space 
narrowing.
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kg/d, followed by 4 months of double-therapy continuation phase 
with INH and RMP. In cases where relapse would have especially 
disastrous consequences (spinal TB) or if it would go unnoticed, 
the continuation phase should extend for 12 months. If there is any 
suspicion of drug resistance, ETA 15 - 25 mg/kg/d should be added 
for all phases. Seddon et al.[19] treated seven children with culture-
confirmed spinal MDR-TB in Cape Town, SA, between 2004 and 2010 
using the WHO general guidelines (treatment of at least 18 months’ 
duration with at least four drugs to which the organism is susceptible, 
incorporating an initial 6-month intensive phase using at least one 
injectable drug). They reported that all six surviving children at 
the end of the study had tolerated the treatment well with positive 
clinical outcomes and fewer side-effects than expected. Adding to 
these recommendations, Al-Dabbagh et al.[5] stressed that three of the 
selected drugs should not have been administered before, two should 
be bactericidal, and if possible, either an injectable aminoglycoside 
or fluoroquinolone should be used during the intensive phase. They 
also placed the appropriate multidrug regimen within an effective 
treatment plan involving reliable drug susceptibility testing, directly 
observed therapy by a specialised team to ensure adherence, and 
close monitoring and management of expected side-effects specific 
to the drugs.[1,5]
Surgery for diagnosis of ESOA TB is essential, and with the 
high rate of bacterial co-infection as seen in this study, drainage, 
debridement and washout of the joint is important. Surgery played an 
important role in both the cases presented above. Traditionally, spinal 
TB has been treated non-surgically because of excellent results with 
non-surgical treatment, extending even to resolution of erosions, 
and improvement in vertebral height.[29] Surgical indications include 
abscesses causing neurological compromise, septic dislocation and 
treatment of residual instability or deformity secondary to bony 
destruction or growth disturbance.[10,12,13] In the ESOA MDR-TB 
literature, many have observed that surgical treatment appears 
to improve outcome, but no formal statistical analysis has been 
performed.[19,29] In contrast, it is well established in the pulmonary 
literature on MDR-TB that surgery improves the chance of a 
favourable outcome.[30]
Study limitations
The study had a number of limitations. It was retrospective, the 
focus being to look at the prevalence of ESOA MDR-TB in children 
at a tertiary institution, which may have skewed the sample 
towards being less representative of the general population. The 
number of cases seen at a regional hospital should be minimal, 
however, as all paediatric orthopaedic pathology is referred to the 
study hospital. The positive TB cultures required for inclusion 
of the study population meant that a potentially large number of 
patients who were treated for ESOA TB based on clinical grounds 
were excluded.
Conclusions
There was a relatively high prevalence of paediatric ESOA MDR-TB 
(10.5%) in this population. This finding should stimulate vigilance 
with regard to rapid and reliable early means of detection with 
newer genetic tests and drug susceptibility testing in all cases, 
with knowledge of and adherence to published specific treatment 
guidelines. Appropriate chemotherapy should be rapidly initiated, 
aggressive and prolonged, and adjunctive surgery is always indicated 
for initial debridement and diagnostic sampling.
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